The Latest Cardiac and Vascular News
Financial and Operational Highlights for Quarter Ended September 30, 2021 NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the first quarter ended September 30, 2021, and an update on its pipeline […]
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020 Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020 Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020 Q3 2021 non-GAAP EPS* of $0.52, compared to […]
IRVINE, Calif., Oct. 27, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2021. Third Quarter Highlights and 2021 Outlook Sales grew 15 percent to $1.3 billion; underlying1 sales grew 14 percent TAVR sales grew 15 percent; underlying 14 percent U.S. TAVR sales grew 12 percent; OUS approximately 20 […]
MARLBOROUGH, Mass., Oct. 27, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported basis, 9.7 percent on an operational1 basis and 10.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended September 30, 2021. Q2 financial summary and operational highlights: Revenue for the quarter totaled $248.1 million, an increase of 18% compared to $209.8 million during the same period of […]
JENKINTOWN, Pa., Oct. 28, 2021 /PRNewswire/ — Adler Institute for Advanced Imaging and KDK Scientific, the leading independent clinical and research imaging facility in the Greater Philadelphia region, are excited to announce the expansion of their existing Cardiac PET/CT imaging services, with the installation of a dedicated superconducting cyclotron for the manufacture and production […]
Company Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After Stroke AUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) announced today its plan to commence a randomized, placebo-controlled clinical study to test its new True Human™ antibody therapy […]
CINCINNATI, Oct. 28, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer (EVP, CFO and CBDO). “Terry gained broad financial and operational leadership experience at several high-profile and start-up companies, including in […]
WAYNE, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter financial summary Reported revenues of $700.3 million, up 11.5% year-over-year; up 10.3% on a constant currency basis GAAP diluted EPS from continuing operations of […]
IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced positive acute and long-term interim results from the first 500 pulmonary embolism (“PE”) patients […]
